These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 21283156)

  • 1. Comparison of antibiotic-only and antibiotic-steroid combination treatment in corneal ulcer patients: double-blinded randomized clinical trial.
    Blair J; Hodge W; Al-Ghamdi S; Balabanian R; Lowcock B; Pan YI; Sherif H; AlMahmoud T; Fergusson D; Slomovic A
    Can J Ophthalmol; 2011 Feb; 46(1):40-5. PubMed ID: 21283156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized clinical study for comparative evaluation of fourth-generation fluoroquinolones with the combination of fortified antibiotics in the treatment of bacterial corneal ulcers.
    Shah VM; Tandon R; Satpathy G; Nayak N; Chawla B; Agarwal T; Sharma N; Titiyal JS; Vajpayee RB
    Cornea; 2010 Jul; 29(7):751-7. PubMed ID: 20489580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticosteroids for bacterial keratitis: the Steroids for Corneal Ulcers Trial (SCUT).
    Srinivasan M; Mascarenhas J; Rajaraman R; Ravindran M; Lalitha P; Glidden DV; Ray KJ; Hong KC; Oldenburg CE; Lee SM; Zegans ME; McLeod SD; Lietman TM; Acharya NR;
    Arch Ophthalmol; 2012 Feb; 130(2):143-50. PubMed ID: 21987582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The steroids for corneal ulcers trial: study design and baseline characteristics.
    Srinivasan M; Mascarenhas J; Rajaraman R; Ravindran M; Lalitha P; Glidden DV; Ray KJ; Hong KC; Oldenburg CE; Lee SM; Zegans ME; McLeod SD; Lietman TM; Acharya NR;
    Arch Ophthalmol; 2012 Feb; 130(2):151-7. PubMed ID: 21987581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The steroids for corneal ulcers trial (SCUT): secondary 12-month clinical outcomes of a randomized controlled trial.
    Srinivasan M; Mascarenhas J; Rajaraman R; Ravindran M; Lalitha P; O'Brien KS; Glidden DV; Ray KJ; Oldenburg CE; Zegans ME; Whitcher JP; McLeod SD; Porco TC; Lietman TM; Acharya NR;
    Am J Ophthalmol; 2014 Feb; 157(2):327-333.e3. PubMed ID: 24315294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of moxifloxacin 0.5% in treatment of nonperforated bacterial corneal ulcers: a randomized controlled trial.
    Sharma N; Goel M; Bansal S; Agarwal P; Titiyal JS; Upadhyaya AD; Vajpayee RB
    Ophthalmology; 2013 Jun; 120(6):1173-8. PubMed ID: 23415776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of topical gatifloxacin 0.3% and ciprofloxacin 0.3% for the treatment of bacterial keratitis.
    Parmar P; Salman A; Kalavathy CM; Kaliamurthy J; Prasanth DA; Thomas PA; Jesudasan CA
    Am J Ophthalmol; 2006 Feb; 141(2):282-286. PubMed ID: 16458681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nocardia keratitis: clinical course and effect of corticosteroids.
    Lalitha P; Srinivasan M; Rajaraman R; Ravindran M; Mascarenhas J; Priya JL; Sy A; Oldenburg CE; Ray KJ; Zegans ME; McLeod SD; Lietman TM; Acharya NR
    Am J Ophthalmol; 2012 Dec; 154(6):934-939.e1. PubMed ID: 22959881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corticosteroids for bacterial corneal ulcers.
    Srinivasan M; Lalitha P; Mahalakshmi R; Prajna NV; Mascarenhas J; Chidambaram JD; Lee S; Hong KC; Zegans M; Glidden DV; McLeod S; Whitcher JP; Lietman TM; Acharya NR
    Br J Ophthalmol; 2009 Feb; 93(2):198-202. PubMed ID: 18829631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The successful treatment of gatifloxacin-resistant Staphylococcus aureus keratitis with Zymar (gatifloxacin 0.3%) in a NZW rabbit model.
    Romanowski EG; Mah FS; Yates KA; Kowalski RP; Gordon YJ
    Am J Ophthalmol; 2005 May; 139(5):867-77. PubMed ID: 15860293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudomonas aeruginosa keratitis: outcomes and response to corticosteroid treatment.
    Sy A; Srinivasan M; Mascarenhas J; Lalitha P; Rajaraman R; Ravindran M; Oldenburg CE; Ray KJ; Glidden D; Zegans ME; McLeod SD; Lietman TM; Acharya NR
    Invest Ophthalmol Vis Sci; 2012 Jan; 53(1):267-72. PubMed ID: 22159005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ofloxacin monotherapy for the primary treatment of microbial keratitis: a double-masked, randomized, controlled trial with conventional dual therapy. The Ofloxacin Study Group.
    Ophthalmology; 1997 Nov; 104(11):1902-9. PubMed ID: 9373124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subgroup analysis in the steroids for corneal ulcers trial.
    Dulku S
    Arch Ophthalmol; 2012 Jun; 130(6):807-8; author reply 808. PubMed ID: 22801856
    [No Abstract]   [Full Text] [Related]  

  • 14. Adjunctive use of intravitreal dexamethasone in presumed bacterial endophthalmitis: a randomised trial.
    Albrecht E; Richards JC; Pollock T; Cook C; Myers L
    Br J Ophthalmol; 2011 Oct; 95(10):1385-8. PubMed ID: 21289020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visual outcomes in treated bacterial keratitis: four years of prospective follow-up.
    McClintic SM; Prajna NV; Srinivasan M; Mascarenhas J; Lalitha P; Rajaraman R; Oldenburg CE; O'Brien KS; Ray KJ; Acharya NR; Lietman TM; Keenan JD
    Invest Ophthalmol Vis Sci; 2014 May; 55(5):2935-40. PubMed ID: 24618327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gatifloxacin 0.3% Versus Fortified Tobramycin-Cefazolin in Treating Nonperforated Bacterial Corneal Ulcers: Randomized, Controlled Trial.
    Sharma N; Arora T; Jain V; Agarwal T; Jain R; Jain V; Yadav CP; Titiyal J; Satpathy G
    Cornea; 2016 Jan; 35(1):56-61. PubMed ID: 26509763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacteria commonly isolated from keratitis specimens retain antibiotic susceptibility to fluoroquinolones and gentamicin plus cephalothin.
    Ly CN; Pham JN; Badenoch PR; Bell SM; Hawkins G; Rafferty DL; McClellan KA
    Clin Exp Ophthalmol; 2006; 34(1):44-50. PubMed ID: 16451258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical efficacy of moxifloxacin in the treatment of bacterial keratitis: a randomized clinical trial.
    Constantinou M; Daniell M; Snibson GR; Vu HT; Taylor HR
    Ophthalmology; 2007 Sep; 114(9):1622-9. PubMed ID: 17822972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of ophthalmic gatifloxacin 0.3% and ciprofloxacin 0.3% in healing of corneal ulcers associated with Pseudomonas aeruginosa-induced ulcerative keratitis in rabbits.
    Jensen H; Zerouala C; Carrier M; Short B
    J Ocul Pharmacol Ther; 2005 Feb; 21(1):36-43. PubMed ID: 15718826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of topical 0.3% ofloxacin with fortified tobramycin plus cefazolin in the treatment of bacterial keratitis.
    Panda A; Ahuja R; Sastry SS
    Eye (Lond); 1999 Dec; 13 ( Pt 6)():744-7. PubMed ID: 10707137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.